Literature DB >> 17445546

Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus.

Yoshiharu Tokuyama1, Haruhiko Osawa, Toshiharu Ishizuka, Hiroshi Onuma, Kana Matsui, Toru Egashira, Hideichi Makino, Azuma Kanatsuka.   

Abstract

Impaired insulin secretion and decreased insulin sensitivity are the main pathophysiologic features responsible for development of hyperglycemia in type 2 diabetes mellitus. Insulin resistance is often associated with increased adipose tissue mass. To examine which variables influence insulin sensitivity, we compared metabolic parameters, serum resistin, leptin, and adiponectin concentrations to the insulin sensitivity, obtained by frequently sampled intravenous glucose tolerance test using the minimal model analysis, in 113 Japanese patients with type 2 diabetes mellitus. Duration of diabetes, fasting plasma glucose, fasting insulin, homeostasis model assessment of insulin resistance index, and serum resistin concentration were significantly higher in the insulin-resistant subgroup compared with the insulin-sensitive subgroup and correlated with insulin sensitivity. Stepwise regression analysis also identified these parameters as independent regulators of insulin sensitivity. The present study reconfirmed that fasting insulin level or homeostasis model assessment of insulin resistance would be a surrogate measure of insulin resistance and demonstrated that insulin resistance increases progressively after the onset of overt diabetes and that the serum resistin level is associated with insulin sensitivity, suggesting that resistin plays an important role in the development of insulin resistance in Japanese patients with type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445546     DOI: 10.1016/j.metabol.2006.12.019

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Resistin does not down-regulate the transcription of insulin receptor promoter.

Authors:  Xiao-zhi Qiao; Xian-feng Wang; Zhe-rong Xu; Yun-mei Yang
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

2.  Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus.

Authors:  Sema Uslu; Nur Kebapçi; Mehmet Kara; Cengiz Bal
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

3.  Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women.

Authors:  Christin Heidemann; Qi Sun; Rob M van Dam; James B Meigs; Cuilin Zhang; Shelley S Tworoger; Christos S Mantzoros; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

4.  Beneficial Effects of n-3 Fatty Acids on Cardiometabolic and Inflammatory Markers in Type 2 Diabetes Mellitus: A Clinical Trial.

Authors:  Maryam Mazaherioun; Mahmoud Djalali; Fariba Koohdani; Mohammad Hassan Javanbakht; Mahnaz Zarei; Maani Beigy; Samaneh Ansari; Neda Rezvan; Ahmad Saedisomeolia
Journal:  Med Princ Pract       Date:  2017-10-10       Impact factor: 1.927

Review 5.  Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.

Authors:  Osinakachukwu Mbata; Nada Fawzy Abo El-Magd; Azza Bahram El-Remessy
Journal:  World J Diabetes       Date:  2017-07-15

6.  Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.

Authors:  M Gorety Jacobo-Cejudo; Roxana Valdés-Ramos; Ana L Guadarrama-López; Rosa-Virgen Pardo-Morales; Beatriz E Martínez-Carrillo; Laurence S Harbige
Journal:  Nutrients       Date:  2017-06-03       Impact factor: 5.717

7.  Relevance of single-nucleotide polymorphism to the expression of resistin gene affecting serum and gingival crevicular fluid resistin levels in chronic periodontitis and type 2 diabetes mellitus: A randomized control clinical trial.

Authors:  Pranita Avinash Rode; Rajashri Abhay Kolte; Abhay Pandurang Kolte; Hemant Jyotiswarup Purohit; Charu Ram Ahuja
Journal:  J Indian Soc Periodontol       Date:  2019 Mar-Apr

8.  Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.

Authors:  Panayoula C Tsiotra; Constantine Tsigos; Eleni Anastasiou; Eleni Yfanti; Eleni Boutati; Emmanouil Souvatzoglou; Ioannis Kyrou; Sotirios A Raptis
Journal:  Mediators Inflamm       Date:  2008-12-21       Impact factor: 4.711

9.  Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts.

Authors:  Brian H Chen; Yiqing Song; Eric L Ding; Christian K Roberts; JoAnn E Manson; Nader Rifai; Julie E Buring; J Michael Gaziano; Simin Liu
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 17.152

10.  Measurement of salivary resistin level in patients with type 2 diabetes.

Authors:  Jinhua Yin; Hongfei Gao; Jing Yang; Lu Xu; Ming Li
Journal:  Int J Endocrinol       Date:  2012-08-30       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.